Stock market analysts and brokers have recently amended their target prices on shares of United Therapeutics Corporation (NASDAQ:UTHR). On average, analysts expect that United Therapeutics Corporation will report full year sales of …
United Therapeutics ... like VRX stock and QCOR stock to see if the growth compares well with what can be expected for a company in that industry. Bottom line: The word bottom line comes because it is usually the last line of the …
Girard Gibbs LLP is investigating potential claims on behalf of investors of United Therapeutics Corporation …
Krensavage Asset Management Llc sold 4,855 shares as United Therapeutics Corp (UTHR)’s stock declined 27.66%. …
Moreover, Sg Americas Securities Ltd Co has 0.03% invested in United Therapeutics Corporation (NASDAQ:UTHR) for …
It has underperformed by 16.70% the S&P500. The stock of United Therapeutics Corporation (NASDAQ:UTHR) earned "Neutral" rating by Ladenburg Thalmann on Friday, April 29. UTHR's profit will be $164.07M for 9.40 P/E if the $3.58 …
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of United Therapeutics Corp (NASD: UTHR) entered into oversold territory, hitting an RSI reading of 29.0, after changing hands as low as …
The year-to-date return of United Therapeutics Corporation (NASDAQ:UTHR)’s stock is almost 34%, and it trades at a …
For the week, the stock is performing 1.49%. Manufacturers Life The reported 0.01% stake. Several other institutional investors have also made changes to their positions in UTHR. 04/03/2017 - United Therapeutics Corporation was …
Stock market analysts and brokers have recently amended their target prices on shares of United Therapeutics Corporation (NASDAQ:UTHR). According to the latest research reports released, 2 analysts have issued a rating of …